Dupilumab Faces Trial in Chronic Hives - Poll - MDSpire

Dupilumab Faces Trial in Chronic Hives

Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.

  • By

  • Kathryn Wighton

  • March 12, 2026

  • 5 min

Share

Original Source(s)

Dupilumab Faces Trial in Chronic Hives

  • by Kathryn Wighton

  • March 12, 2026

Related Content

Cutaneous Rhabdomyosarcoma May Mask Melanoma

Molecular and epigenetic profiling suggested most tumors in a rare cutaneous sarcoma cohort were better classified as transdifferentiated melanoma.

Efficacy and Safety of Omalizumab in Chinese Pediatric Patients Under 12 with Chronic Urticaria: A Case Series Analysis

Detecting comorbidity patterns in rare disease patients with machine learning